[HTML][HTML] Treatment options for COVID-19: The reality and challenges

SS Jean, PI Lee, PR Hsueh - Journal of microbiology, immunology and …, 2020 - Elsevier
coronavirus disease 2019 (COVID-19) pandemic in 2020. Despite the worsening trends of
COVID-19… significant efficacy in clinical treatment of COVID-19 patients in large-scale studies. …

[HTML][HTML] Remdesivir as a possible therapeutic option for the COVID-19

JA Al-Tawfiq, AH Al-Homoud… - Travel medicine and …, 2020 - ncbi.nlm.nih.gov
… etiologic agent of (COVID-19), we … option for the therapy of patients with COVID-19[10]. In
a case report, remdisivir reatment was started intravenous on day 7 in a patient with COVID-19 […

Natural history of COVID-19 and therapeutic options

P Gautret, M Million, PA Jarrot… - Expert review of …, 2020 - Taylor & Francis
… Introduction: COVID-19 presents benign forms in young patients who … the natural history of
and therapeutic options for COVID-19. … Therapeutic options include antivirals, oxygen therapy, …

Individual risk management strategy and potential therapeutic options for the COVID-19 pandemic

A Gasmi, S Noor, T Tippairote, M Dadar, A Menzel… - Clinical …, 2020 - Elsevier
… have been reported as clinical manifestations of COVID-19 [18,19]. A study from China
also … treatment for COVID-19, we here explore some potential therapeutic options of some …

[HTML][HTML] Natural history of COVID-19 and current knowledge on treatment therapeutic options

WG Dos Santos - Biomedicine & Pharmacotherapy, 2020 - Elsevier
… be a potential therapeutic agent used for COVID-19 patients with this increased Th17 profile
[67]. Therefore, one of the treatment strategies for COVID-19 includes anticytokine therapies …

An update to monoclonal antibody as therapeutic option against COVID-19

P Deb, MMA Molla, KM Saif-Ur-Rahman - Biosafety and Health, 2021 - mednexus.org
… With the number of Coronavirus Disease 2019 (COVID-19) … a viable therapeutic option to
treat COVID-19 disease and its … antibodies used to treat COVID-19, with special attention paid …

The interplay between inflammatory pathways and COVID-19: A critical review on pathogenesis and therapeutic options

S Choudhary, K Sharma, O Silakari - Microbial pathogenesis, 2021 - Elsevier
… led to the mortality in COVID-19 patients. The therapeutic options that may act as a potential
treatment for the inflammatory conditions associated with COVID-19 are also discussed. …

Efficacy and safety of current therapeutic options for COVID-19-lessons to be learnt from SARS and MERS epidemic: A systematic review and meta-analysis

H Zhong, Y Wang, ZL Zhang, YX Liu, KJ Le… - Pharmacological …, 2020 - Elsevier
… This meta-analysis aimed at evaluating the efficacy and safety of current optionCOVID-19,
in an attempt to identify promising therapy for severe acute respiratory syndrome coronavirus

COVID-19: drug targets and potential treatments

C Gil, T Ginex, I Maestro, V Nozal… - Journal of medicinal …, 2020 - ACS Publications
… response to coronavirus infection and the related therapeutic options will be presented. …
to be further evaluated as a therapeutic option for COVID-19 patients, although there are some …

COVID19: immunopathology, pathophysiological mechanisms, and treatment options

LE van Eijk, M Binkhorst, AR Bourgonje… - The Journal of …, 2021 - Wiley Online Library
… available knowledge of COVID-19 immunopathogenesis is … of patients with COVID-19
provide valuable information with … pathological changes observed in COVID-19 within the most …